In the random-effects model meta-analysis, PON-1 activity was found to be significantly lower in RA patients compared to controls (SMD = −1.32, 95% CI −1.94 to −0.70; p < 0.001). The gene discussed is PON1; the disease is rheumatoid arthritis.